Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (191-200 of 419) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R Cressey, Hannah Green, Saye Khoo, et al.
Antiviral Therapy|October 12, 2007
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?Katherine J Lee, Delane Shingadia, Deenan Pillay, et al.
The New England Journal of Medicine|November 21, 2008
Early antiretroviral therapy and mortality among HIV-infected infantsAvy Violari, Mark F Cotton, Diana M Gibb, et al.
Therapeutic Drug Monitoring|April 14, 2010
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tabletsDavid Burger, Fiona Ewings, Desiré Kabamba, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
Journal of Reproduction and Fertility|May 1, 1986
Differences in ovarian activity between booroola X merino ewes which were homozygous, heterozygous and non-carriers of a major gene influencing their ovulation rateK P McNatty, S Lun, D A Heath, et al.
The Pediatric Infectious Disease Journal|April 17, 2014
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected childrenQuirine Fillekes, Lindsay Kendall, Sabrina Kitaka, et al.
Clinical Trials (London, England)|May 17, 2022
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficientlyIan R White, Babak Choodari-Oskooei, Matthew R Sydes, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
AIDS (London, England)|January 6, 2016
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruptionJintanat Ananworanich, Diane Melvin, Jose T R Amador, et al.
Pageof 42

Showing results (191-200 of 419) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R Cressey, Hannah Green, Saye Khoo, et al.
Antiviral Therapy|October 12, 2007
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?Katherine J Lee, Delane Shingadia, Deenan Pillay, et al.
The New England Journal of Medicine|November 21, 2008
Early antiretroviral therapy and mortality among HIV-infected infantsAvy Violari, Mark F Cotton, Diana M Gibb, et al.
Therapeutic Drug Monitoring|April 14, 2010
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tabletsDavid Burger, Fiona Ewings, Desiré Kabamba, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
Journal of Reproduction and Fertility|May 1, 1986
Differences in ovarian activity between booroola X merino ewes which were homozygous, heterozygous and non-carriers of a major gene influencing their ovulation rateK P McNatty, S Lun, D A Heath, et al.
The Pediatric Infectious Disease Journal|April 17, 2014
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected childrenQuirine Fillekes, Lindsay Kendall, Sabrina Kitaka, et al.
Clinical Trials (London, England)|May 17, 2022
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficientlyIan R White, Babak Choodari-Oskooei, Matthew R Sydes, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
AIDS (London, England)|January 6, 2016
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruptionJintanat Ananworanich, Diane Melvin, Jose T R Amador, et al.
Pageof 42